Key Takeaways
- The most common failure mode in multi-site behavioral health growth is not strategic. It is operational: providers expand before they have the financial stability or the talent infrastructure to support what they are adding.
- Cultural integration is the hardest part of a merger or acquisition, not the technology migration, not the payroll transition, and not the branding rollout. Operators who treat cultural alignment as something that happens automatically once a transaction closes tend to discover its importance through attrition.
- Data-driven decision-making applies to growth decisions, not just clinical ones. Operators who cannot quantify why they are ready to expand should not be expanding. Pathways Recovery Centers uses AI-based technology to measure therapeutic alliance at each facility as a leading indicator of cultural health before adding capacity.
- Market saturation and referral source relationships shape geographic strategy. Opening a second location too close to the first can cannibalize the referral pipeline the first location depends on. Sylvia Brafman Mental Health Center expanded to Georgia rather than deeper into Florida specifically to avoid competing with its own residential referral sources.
- Scaled platforms command higher valuations, but only when clinical integrity scales with them. Private-market data shows autism and ABA platforms with strong clinical governance and diversified payer relationships routinely trade at 12 to 15 times EBITDA, with mental health and addiction treatment platforms commanding lower but still premium ranges.
- Employed provider models outperform contractor arrangements in acquisitions. PAX Health prioritizes targets where clinicians are on staff rather than contracted, both for revenue durability and for cultural integration: employed providers are more likely to align with a acquiring organization’s mission and stay through the transition.
The behavioral health industry has spent the past several years in a growth cycle that, by most measures, shows no sign of reversing. Approximately 61.5 million American adults experienced a mental illness in 2024, according to SAMHSA, and nearly half of them went without treatment. The substance use disorder landscape is equally strained: an estimated 48.4 million Americans currently live with a diagnosable SUD, with treatment infrastructure that researchers describe as fragmented and undersupplied. That gap between need and access has drawn providers, investors, and platforms into the space at an accelerating rate.
The result has been a wave of acquisition and expansion that, in the right hands, has delivered meaningful improvements in care access. In the wrong ones, it has produced the opposite: facilities that outran their own infrastructure, diluted the clinical quality they were built on, and discovered that growth without discipline is its own kind of failure. Private equity data confirms the pattern: scaled, multi-state behavioral health platforms with strong clinical governance routinely command premium EBITDA multiples, with autism and ABA platforms at the high end of that range, while organizations that grew indiscriminately do not. The spread between those two outcomes is not driven primarily by market conditions. It is driven by decisions that operators make long before a transaction is on the table.
The Two Rules That Govern Successful Behavioral Health Scaling: Never Outgrow Your Money or Your Talent
Drew LaBoon has been at Pathways Recovery Centers since the beginning, starting in admissions, moving through outreach, then the director of admissions and outreach, then director of operations, before reaching his current role as COO. Pathways now operates five treatment centers across three states. Before that trajectory, LaBoon spent 17 years in special operations, completed multiple combat deployments, and went through two inpatient stays and five detoxes before getting sober in 2019 at the Oklahoma facility he now helps run. The arc has given him a particular clarity about what sustains organizations that are growing versus those that are about to break.
“The golden rules need to be: you never outgrow your money or your talent,” LaBoon said. “Everybody I’ve seen come into this industry that fails violates one or both of those rules.”
The financial side of that principle is straightforward in theory and routinely violated in practice. A facility that is not generating enough margin to absorb the carrying costs of a new location, a new license, a new clinical team, and the inevitable ramp-up period before census stabilizes has no business adding any of those things. The talent side is subtler and, in behavioral health, arguably more consequential. Expanding a treatment organization without the clinical leadership, middle management, and ground-level staff to maintain the same standard of care across more sites does not spread good care more widely. It spreads thin care more widely.
LaBoon measures Pathways’ readiness to grow through a metric that most operators would not immediately reach for: therapeutic alliance. The company uses AI-based technology to quantify the quality of the relationships between clinicians and clients at each facility. The logic is that culture, the thing most likely to deteriorate during rapid expansion, reveals itself in those relationships before it shows up anywhere else. “If culture is good, then they’re establishing trust, and they’re establishing positive relationships with each client in a much stronger way,” LaBoon said. “If I look across at my facilities and I’m looking to increase the bed count at one facility, I go in and I measure how’s our culture doing, what do our outcomes look like? And if that’s positive, then I know that even in down times, that’s going to trend back and we’re going to be able to sustain growth.”
The inverse is equally instructive. If the therapeutic alliance data at a given facility is trending downward, that is a signal to investigate before adding capacity, not after. Making a growth decision you cannot quantify, in LaBoon’s framing, is not making a decision at all. “If I can’t quantify my reason for making the decision and project the outcomes of what that decision is going to make, I’m unqualified to make it,” he said.
Cultural Integration Is the Hardest Part of a Behavioral Health Merger: What PAX Health Did to Get Buy-In Fast
Anthony DeSena came to behavioral health from physical therapy, where he had built and exited a multi-state platform through a private equity process. He launched PAX Health in January 2024 with the idea of applying those operational learnings to mental health, and within the year had merged three organizations simultaneously. Three more acquisitions followed in 2025.
His account of what made those integrations work is notable for what it does not emphasize. The tactical checklist, EMR migration, phone system consolidation, payroll alignment, is table stakes. It is the part that can be project-managed. What cannot be project-managed is getting clinicians, front-desk staff, and clinical directors who built something of their own to see themselves as part of something larger.
“You had companies that were very founder-led family-like businesses, mom-and-pop, and getting people into sort of a more corporate mindset was a little tricky,” DeSena said. “But I think we’ve done a really good job of creating the PAX brand, the PAX culture. When people really got to understand the mission and the why behind what we’re doing, I think we had some pretty good buy-in really quickly.”
Getting to that buy-in required something that does not appear on an integration timeline: road shows. DeSena traveled to each acquired organization to tell the story in person, to explain where the company was going and why, and to give staff a frame for understanding the acquisition as an opportunity rather than a threat. The operators who skip that step, treating cultural alignment as something that happens automatically once the legal transaction closes, tend to discover its importance the expensive way, through attrition.
PAX’s approach to identifying acquisition targets also reflects a specific set of clinical and operational criteria, not just revenue profiles. DeSena looks for practices with employed provider models: organizations where clinicians are on staff, not contracted. The reasoning is partly financial, employed providers represent more durable revenue than 1099 arrangements, but it is more fundamentally cultural. “Folks that are part of an employed provider model tend to align a little bit better,” DeSena said. “They fly the flag. They’re proud to be a part of us.” Practices with multiple service lines, psychiatry, talk therapy, and psychology, rank higher on the target list because they allow PAX to layer in its neuropsychology program and other offerings without rebuilding from scratch.
Geographic Strategy in Behavioral Health: Why Expanding Into Your Own Referral Market Is an Unforced Error
Jaime Blaustein co-founded The Sylvia Brafman Mental Health Center in September 2021 alongside Ben Brafman, a clinician and former founder of a South Florida substance abuse treatment center. Blaustein came to the partnership from investment banking, following his own experience with addiction and recovery, and brought the strategic function of the business while Brafman ran clinical operations. In January 2025, they opened a second location in Georgia, adding residential beds to a platform that had been operating as a PHP with a housing component in Florida.
The decision to expand out of state rather than deeper into Florida was not accidental. Florida’s mental health PHP market, which Sylvia Brafman had worked to establish itself in, is heavily supplied. Adding a second facility in the same geography risked cannibalizing the referral relationships the first location had spent years building. Residential treatment centers in Florida had become a primary source of step-down referrals for Sylvia Brafman’s PHP program, meaning a Florida residential facility would compete directly with the organizations feeding census to the existing site.
“I felt it would be sort of an unforced error to go start competing with our referral sources,” Blaustein said. “And the supply is also pretty saturated. So I wanted to look elsewhere.”
The Sylvia Brafman Georgia residential program fills a gap in a market with less competitive density and a real need for the specific clinical model the organization has built around primary mental health, not substance use disorder as the primary diagnosis. The distinction matters operationally: a primary mental health residential program requires more robust medical infrastructure, particularly psychiatric medication management, than a standard SUD residential facility. Not every operator can staff and run it credibly. That specificity becomes a competitive advantage in a market where it is genuinely rare.
Blaustein is deliberate about the ceiling he places on growth. He does not want to become a conglomerate, a word he uses with evident intent, and frames future expansion as geographically concentrated in the Southeast rather than nationally distributed. That constraint is not modesty. It is a recognition that the clinical model Sylvia Brafman has built depends on the kind of oversight that becomes genuinely difficult to sustain once geographic distance exceeds what leadership can realistically monitor.
The operators sitting at the intersection of those principles, financial discipline, cultural intentionality, and geographic strategy rooted in referral network logic, are not describing a growth philosophy so much as a set of preconditions. The industry is large enough, and the unmet need deep enough, that the opportunity to expand is not the question. The question is whether the organization in front of you is actually ready for what expansion will ask of it.
Frequently Asked Questions
What are the most common mistakes behavioral health operators make when scaling?
The most consistent failure mode in multi-site behavioral health growth is operational rather than strategic: providers expand before they have the financial stability or the talent infrastructure to support what they are adding. Drew LaBoon, COO of Pathways Recovery Centers, frames it as two inviolable rules: never outgrow your money, and never outgrow your talent. A facility that is not generating sufficient margin to absorb the carrying costs of a new location, including licensing, clinical staffing, and the ramp-up period before census stabilizes, has no business adding one. The talent side is subtler: expanding without the clinical leadership and middle management to maintain the same standard of care across more sites does not spread good care more widely, it spreads thin care more widely. A third common mistake is geographic: opening a second location in a market that already feeds the first risks cannibalizing the referral relationships the existing site depends on for census.
How should behavioral health operators measure readiness to expand?
Pathways Recovery Centers uses therapeutic alliance data, generated through AI-based measurement tools that quantify the quality of relationships between clinicians and clients, as a leading indicator of cultural health before making any capacity expansion decision. The logic is that culture, the factor most likely to deteriorate during rapid growth, reveals itself in clinician-client relationships before it shows up in financial metrics or staff satisfaction surveys. If therapeutic alliance is trending downward at a facility, that is a signal to investigate before adding beds, not after. LaBoon frames the principle directly: “If I can’t quantify my reason for making the decision and project the outcomes of what that decision is going to make, I’m unqualified to make it.” Financial readiness, clinical leadership depth, census stability, and cultural health metrics all need to clear a threshold before a growth decision is credible.
Why is cultural integration the hardest part of a behavioral health merger or acquisition?
Most behavioral health organizations being acquired are founder-led, clinician-driven businesses where staff culture is closely tied to the identity of the people who built them. When those organizations are absorbed into a larger platform, clinicians, front-desk staff, and clinical directors who built something of their own have to be persuaded to see themselves as part of something larger. That transition cannot be project-managed in the same way as an EMR migration or a payroll system consolidation. Anthony DeSena of PAX Health, which executed six acquisitions in its first two years, addressed this through road shows: traveling to each acquired organization to explain the company’s mission and the rationale for the acquisition in person before the transition fully closed. The operators who skip that step and assume cultural alignment will emerge naturally from a completed transaction tend to lose staff through attrition in the months that follow, which converts a growth move into a capacity problem.
How does geographic strategy affect multi-site behavioral health growth?
Geographic strategy in behavioral health must account for referral network dependencies in ways that are often counterintuitive. A second location in the same market as the first may seem like a natural expansion, but if the first location depends on referrals from residential treatment centers, skilled nursing facilities, or other providers in that market, a same-market facility can compete directly with its own referral sources. Jaime Blaustein of The Sylvia Brafman Mental Health Center chose Georgia for the organization’s second location rather than a second Florida site specifically because Florida’s residential treatment centers had become a primary source of step-down referrals for the existing PHP program. Opening a Florida residential facility would have put Sylvia Brafman in competition with the organizations feeding its core program. Geographic expansion into markets with less competitive density and genuine unmet need for a specific clinical model also creates defensible positioning that a same-market expansion cannot.
How does scaling affect behavioral health practice valuations?
Scaled behavioral health platforms command higher EBITDA multiples than single-site or subscale operators, but only when clinical integrity scales with them. Private-market data shows that autism and ABA platforms with strong clinical governance, diversified payer relationships, and multi-state operations routinely trade at 12 to 15 times EBITDA. Mental health and addiction treatment platforms command lower but still premium ranges when they demonstrate similar clinical and operational characteristics. The organizations that grew indiscriminately, accepting patients beyond their clinical capacity or expanding without the management infrastructure to maintain quality, do not command those multiples regardless of their size. The spread between disciplined and undisciplined growth is not driven primarily by market conditions. It is driven by decisions operators make long before any transaction is on the table.
What acquisition criteria do operationally disciplined behavioral health platforms use?
PAX Health’s Anthony DeSena prioritizes three criteria in acquisition targets. First, employed provider models: organizations where clinicians are on staff rather than contracted on a 1099 basis. Employed providers represent more durable revenue than contractor arrangements and tend to integrate more smoothly into an acquiring organization’s culture. Second, multiple service lines: practices offering psychiatry, talk therapy, and psychology create opportunities to layer in additional offerings, such as PAX’s neuropsychology program, without rebuilding from scratch. Third, mission alignment: founders and clinical directors who understand and are drawn to the acquiring platform’s stated purpose are more likely to stay through and after the integration period. DeSena’s cultural integration process, which includes in-person road shows at each acquired organization before the transition fully closes, is designed to surface and address misalignments before they become attrition problems. Revenue profile and financial performance matter, but they are evaluated within this clinical and cultural framework rather than as the primary filter.
